[vc_row full_width=”stretch_row_content_no_spaces” content_placement=”top” css=”.vc_custom_1617805845752{margin-top: -30px !important;margin-bottom: 100px !important;border-bottom-width: 30px !important;padding-top: 20px !important;padding-bottom: 20px !important;background-color: #ffffff !important;}”][vc_column width=”1/6″][/vc_column][vc_column css_animation=”fadeIn” width=”2/3″ css=”.vc_custom_1617805325193{padding-top: -30px !important;background-color: #ffffff !important;}”][vc_custom_heading text=”Elevate your standard of care” font_container=”tag:h1|font_size:60|text_align:center|color:%23003a5c” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css_animation=”fadeInUp” css=”.vc_custom_1617803447177{margin-top: 0px !important;padding-top: 0px !important;}”][/vc_column][vc_column width=”1/6″][/vc_column][/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1617755844888{background-color: #003a5c !important;}”][vc_column width=”1/2″ css=”.vc_custom_1617717261696{background-color: #003a5c !important;}”][vc_empty_space][vc_custom_heading text=”Then” font_container=”tag:h2|font_size:24|text_align:left|color:%23d3441c” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css_animation=”slideInLeft”][vc_custom_heading text=”We invented the world’s first spinal navigation device designed to improve the safety, speed, and efficiency of epidural and spinal anesthesia.” font_container=”tag:h2|font_size:17|text_align:left|color:%23ffffff” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:400%20regular%3A400%3Anormal” css_animation=”slideInLeft”][vc_custom_heading text=”And Now” font_container=”tag:h2|font_size:24|text_align:left|color:%23d3441c” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css_animation=”slideInLeft”][vc_custom_heading text=”We’re pleased to share UK’s NICE MIB to help decision-makers like you choose Accuro.” font_container=”tag:h2|font_size:17|text_align:left|color:%23ffffff” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:400%20regular%3A400%3Anormal” css_animation=”slideInLeft”][/vc_column][vc_column width=”1/2″ css=”.vc_custom_1617747899874{background-color: #003a5c !important;}”][vc_video link=”https://www.youtube.com/watch?v=NR3qvooW4tU”][vc_custom_heading text=”Watch this short video message from Will, our CEO and co-founder, on UK’s NICE Medtech innovation briefing (MIB245) on Accuro.” font_container=”tag:h2|font_size:17|text_align:center|color:%23ffffff|line_height:1″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:400%20regular%3A400%3Anormal” css_animation=”none” css=”.vc_custom_1617831384369{padding-top: -20px !important;}”][/vc_column][/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1617755844888{background-color: #003a5c !important;}”][vc_column width=”1/4″ css=”.vc_custom_1617717261696{background-color: #003a5c !important;}”][/vc_column][vc_column css_animation=”fadeIn” width=”1/4″ css=”.vc_custom_1617759628490{background-color: #003a5c !important;}”][vc_btn title=”Why Accuro” style=”outline-custom” outline_custom_color=”#ffffff” outline_custom_hover_background=”#d3441c” outline_custom_hover_text=”#ffffff” shape=”round” align=”center” css=”.vc_custom_1617806656216{padding-top: -10px !important;}” link=”url:https%3A%2F%2Fdev-rivannamedical.pantheonsite.io%2Fwhy-accuro%2F||target:%20_blank|”][/vc_column][vc_column css_animation=”fadeIn” width=”1/4″ css=”.vc_custom_1617759649625{background-color: #003a5c !important;}”][vc_btn title=”No-Cost Evaluation” style=”outline-custom” outline_custom_color=”#ffffff” outline_custom_hover_background=”#d3441c” outline_custom_hover_text=”#ffffff” shape=”round” align=”center” css=”.vc_custom_1617757753406{padding-top: -10px !important;}” link=”url:https%3A%2F%2Fdev-rivannamedical.pantheonsite.io%2Fcontact%2F||target:%20_blank|”][/vc_column][vc_column width=”1/4″][/vc_column][/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1617755844888{background-color: #003a5c !important;}”][vc_column width=”1/4″ css=”.vc_custom_1617717261696{background-color: #003a5c !important;}”][/vc_column][vc_column width=”1/4″ css=”.vc_custom_1617747899874{background-color: #003a5c !important;}”][vc_single_image image=”27264″ img_size=”320×440″ alignment=”right” onclick=”custom_link” img_link_target=”_blank” css_animation=”fadeIn” link=”https://www.nice.org.uk/advice/mib245″][/vc_column][vc_column width=”1/4″ css=”.vc_custom_1617747967801{padding-top: 20px !important;}”][vc_empty_space height=”1px”][vc_custom_heading text=”Commentary from clinical experts included in the briefing stated that Accuro could replace the standard of care.” font_container=”tag:h2|font_size:20|text_align:center|color:%23ffffff” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:400%20regular%3A400%3Anormal” css_animation=”fadeIn”][vc_custom_heading text=”Medtech innovation briefings (MIBs) are NICE advice. They are designed to support NHS and social care commissioners and staff who are considering using new medical devices and other medical or diagnostic technologies.” font_container=”tag:h4|font_size:12|text_align:center|color:%23ffffff” google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:400%20regular%3A400%3Anormal” css_animation=”fadeInUp”][vc_empty_space height=”1px”][vc_btn title=”NICE Briefing” style=”outline-custom” outline_custom_color=”#ffffff” outline_custom_hover_background=”#d3441c” outline_custom_hover_text=”#ffffff” shape=”round” align=”center” css_animation=”slideInUp” link=”url:https%3A%2F%2Fwww.nice.org.uk%2Fadvice%2Fmib245||target:%20_blank|”][/vc_column][vc_column width=”1/4″][/vc_column][/vc_row]
Recent Posts
- From Palpation to Precision: How Simulation Transforms Epidural Training Success Rates
- RIVANNA secures $800,000 Virginia Catalyst Grant alongside matching funds to advance AI-enabled ultrasound platform for neuraxial anesthesia
- Where Do Handheld Devices Fit in the Modern Ultrasound Ecosystem?
- Which State Should Be Most Concerned About Epidural Headaches?
- 58% of Highly Engaged Hospital Staff Report Top Patient Safety Culture Scores